Page last updated: 2024-10-30

metformin and Deaf Mutism

metformin has been researched along with Deaf Mutism in 5 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"To compare the risk of hearing loss with regard to metformin exposure."8.31Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study. ( Tseng, CH, 2023)
"To compare the risk of hearing loss with regard to metformin exposure."4.31Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study. ( Tseng, CH, 2023)
"Metformin treatment will protect mice from noise-induced hearing loss (NIHL)."1.91Metformin Protects Against Noise-Induced Hearing Loss in Male Mice. ( Amanipour, R; Elkon, R; Hertzano, R; Kennedy, CL; Milon, B; Patel, P; Shuster, B, 2023)
"m."1.72Neurological manifestations in m.3243A>G-related disease triggered by metformin. ( Chan, KW; Ching, CK; Lam, SF; Lee, HH; Li, JK; Sheng, B; Tam, HV; Tong, HF; Tong, TT, 2022)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Tong, HF1
Lee, HH1
Tong, TT1
Lam, SF1
Sheng, B1
Chan, KW1
Li, JK1
Tam, HV1
Ching, CK1
Tseng, CH1
Kennedy, CL1
Shuster, B1
Amanipour, R1
Milon, B1
Patel, P1
Elkon, R1
Hertzano, R1
Kim, NH1
Siddiqui, M1
Vogel, J1
Atabek, ME1

Other Studies

5 other studies available for metformin and Deaf Mutism

ArticleYear
Neurological manifestations in m.3243A>G-related disease triggered by metformin.
    Journal of diabetes and its complications, 2022, Volume: 36, Issue:3

    Topics: Deafness; Diabetes Mellitus; DNA, Mitochondrial; Hearing Loss; Humans; MELAS Syndrome; Metformin

2022
Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2023, Volume: 168, Issue:6

    Topics: Deafness; Diabetes Mellitus, Type 2; Hearing; Hearing Loss; Humans; Hypoglycemic Agents; Incidence;

2023
Metformin Protects Against Noise-Induced Hearing Loss in Male Mice.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2023, 10-01, Volume: 44, Issue:9

    Topics: Animals; Cochlea; Deafness; Ear, Inner; Female; Hearing Loss, Noise-Induced; Male; Metformin; Mice;

2023
MELAS Syndrome and MIDD Unmasked by Metformin Use: A Case Report.
    Annals of internal medicine, 2021, Volume: 174, Issue:1

    Topics: Adult; Brain; Deafness; Diabetes Mellitus, Type 2; Diagnosis, Differential; Electroencephalography;

2021
Re: "Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome", Sinha SK et al., JPEM 2007; 20: 1045-1052.
    Journal of pediatric endocrinology & metabolism : JPEM, 2008, Volume: 21, Issue:1

    Topics: Child; Deafness; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents;

2008